Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of efficacy and health-related quality of life of first-line haploidentical hematopoietic stem cell transplantation with unrelated cord blood infusion and first-line immunosuppressive therapy for acquired severe aplastic anemia.
Liu L, Zhang Y, Jiao W, Zhou H, Wang Q, Jin S, Cai Y, Zhao L, Shangguan X, Liu Z, Xu J, Lei M, Yan X, Miao M, Wu D. Liu L, et al. Among authors: jiao w. Leukemia. 2020 Dec;34(12):3359-3369. doi: 10.1038/s41375-020-0933-7. Epub 2020 Jun 26. Leukemia. 2020. PMID: 32591644
Comparison of 2 Different Rabbit Anti-Thymocyte Globulin (r-ATG) Preparations: Thymocyte r-ATG versus T Lymphoblast Cell Line r-ATG in Allogeneic Hematopoietic Stem Cell Transplantation for Acquired Severe Aplastic Anemia: Propensity Score-Matched Analysis.
Liu L, Xu G, Zhang Y, Jiao W, Lei M, Zhou H, Wang Q, Qiu H, Tang X, Han Y, Fu C, Jin Z, Chen S, Sun A, Miao M, Wu D. Liu L, et al. Among authors: jiao w. Transplant Cell Ther. 2021 Feb;27(2):186.e1-186.e3. doi: 10.1016/j.bbmt.2020.08.020. Epub 2020 Aug 21. Transplant Cell Ther. 2021. PMID: 32829081 Free article.
Inefficacy of Immunosuppressive Therapy for Severe Aplastic Anemia Progressing From Non-SAA: Improved Outcome After Allogeneic Hematopoietic Stem Cell Transplantation.
Liu L, Zhao X, Miao M, Zhang Y, Jiao W, Lei M, Zhou H, Wang Q, Cai Y, Zhao L, Shangguan X, Liu Z, Xu J, Zhang F, Wu D. Liu L, et al. Among authors: jiao w. Front Oncol. 2021 Sep 21;11:739561. doi: 10.3389/fonc.2021.739561. eCollection 2021. Front Oncol. 2021. PMID: 34621679 Free PMC article.
Comparable Outcomes and Health-Related Quality of Life for Severe Aplastic Anemia: Haploidentical Combined With a Single Cord Blood Unit vs Matched Related Transplants.
Lei M, Li X, Zhang Y, Qu Q, Jiao W, Zhou H, Wang Q, Qiu H, Tang X, Han Y, Fu C, Jin Z, Chen S, Sun A, Miao M, Liu L, Wu D. Lei M, et al. Among authors: jiao w. Front Oncol. 2022 Jan 18;11:714033. doi: 10.3389/fonc.2021.714033. eCollection 2021. Front Oncol. 2022. PMID: 35117985 Free PMC article.
Comparison of Haploidentical Hematopoietic Stem Cell Transplant With or Without Unrelated Cord Blood Infusion in Severe Aplastic Anemia: Outcomes of a Multicenter Study.
Lei M, Zhang Y, Jiao W, Li X, Zhou H, Wang Q, Qiu H, Tang X, Han Y, Fu C, Jin Z, Chen S, Sun A, Miao M, Liu L, Wu D. Lei M, et al. Among authors: jiao w. Front Immunol. 2022 Jun 23;13:912917. doi: 10.3389/fimmu.2022.912917. eCollection 2022. Front Immunol. 2022. PMID: 35812409 Free PMC article. Clinical Trial.
1,456 results